The effect of cholesteryl ester transfer protein-629C→A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides

被引:59
作者
Borggreve, SE [1 ]
Hillege, HL
Wolffenbuttel, BHR
de Jong, PE
Bakker, SJL
van der Steege, G
van Tol, A
Dullaart, RPF
机构
[1] Univ Groningen, Med Ctr, Dept Endocrinol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Med Ctr, Dept Cardiol, NL-9700 RB Groningen, Netherlands
[3] Univ Groningen, Med Ctr, Dept Nephrol, NL-9700 RB Groningen, Netherlands
[4] Univ Groningen, Med Ctr, Dept Clin Pharmacol, NL-9700 RB Groningen, Netherlands
[5] Univ Groningen, Med Ctr, Dept Internal Med, NL-9700 RB Groningen, Netherlands
[6] Univ Groningen, Med Ctr, Dept Genotyping Facil, NL-9700 RB Groningen, Netherlands
[7] Univ Groningen, Med Ctr, Dept Med Biol, NL-9700 RB Groningen, Netherlands
[8] Erasmus Univ, Med Ctr, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands
关键词
D O I
10.1210/jc.2005-0182
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: The -629C -> A cholesteryl ester transfer protein (CETP) promoter polymorphism is a determinant of HDL cholesterol (HDL-C). The effect of the closely linked CETP TaqIB polymorphism on HDL-C has been suggested to be modified by obesity and hyperinsulinemia. Objective: Because the CETP-mediated cholesteryl ester transfer out of HDL is stimulated by high triglycerides, we hypothesized that triglycerides modify the effect of the CETP-629C -> A promoter polymorphism on HDL-C. Design: In 7083 nondiabetic subjects of the PREVEND population, the -629C -> A promoter polymorphism, HDL-C, serum triglycerides, waist circumference, and insulin resistance (HOMA(ir)) were determined. Serum apolipoprotein A-I was available in 6948 subjects. The TaqIB polymorphism was also assessed. Setting: The study is set in the general community. Results: HDL-C and serum apolipoprotein A-I were on average 0.14 mmol/liter and 0.05 g/liter higher in -629AA ( 22.9%) compared to -629CC (26.8%) homozygotes ( P < 0.001 for both). This genotype effect on HDL-C was on average 0.15 mmol/liter in the lowest triglyceride tertile but only 0.08 mmol/liter in the highest tertile ( P < 0.01). Multiple regression analysis showed that HDL-C was determined by the CETP promoter variant ( P < 0.001), gender ( P < 0.001), triglycerides ( P < 0.001), and interactions between triglycerides and genotype ( P < 0.05), between triglycerides and gender ( P < 0.05), and between genotype and gender ( P < 0.05), independently from waist, HOMAir, alcohol use, age, and use of lipid-lowering drugs. The TaqIB polymorphism also interacted with triglycerides on HDL-C. The -629C -> A promoter polymorphism did not interact with obesity and HOMAir on HDL-C. Conclusions: The HDL-C-raising effect of the CETP-629A allele is diminished with higher triglycerides, which may be explained by a predominant effect of triglyceride-rich lipoproteins over circulating CETP itself on cholesteryl ester transfer out of HDL with rising triglycerides.
引用
收藏
页码:4198 / 4204
页数:7
相关论文
共 51 条
[1]   INCREASED PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN IN OBESE SUBJECTS - A POSSIBLE MECHANISM FOR THE REDUCTION OF SERUM HDL CHOLESTEROL LEVELS IN OBESITY [J].
ARAI, T ;
YAMASHITA, S ;
HIRANO, KI ;
SAKAI, N ;
KOTANI, K ;
FUJIOKA, S ;
NOZAKI, S ;
KENO, Y ;
YAMANE, M ;
SHINOHARA, E ;
ISLAM, AHMW ;
ISHIGAMI, M ;
NAKAMURA, T ;
KAMEDATAKEMURA, K ;
TOKUNAGA, K ;
MATSUZAWA, Y .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (07) :1129-1136
[2]   High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport [J].
Assmann, G ;
Schulte, H ;
vonEckardstein, A ;
Huang, YD .
ATHEROSCLEROSIS, 1996, 124 :S11-S20
[3]   Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment - Individual patient meta-analysis of 13,677 subjects [J].
Boekholdt, SM ;
Sacks, FM ;
Jukema, JW ;
Shepherd, J ;
Freeman, DJ ;
McMahon, AD ;
Cambien, F ;
Nicaud, V ;
de Grooth, GJ ;
Talmud, PJ ;
Humphries, SE ;
Miller, GJ ;
Eiriksdottir, G ;
Gudnason, V ;
Kauma, H ;
Kakko, S ;
Savolainen, MJ ;
Arca, M ;
Montali, A ;
Liu, S ;
Lanz, HJ ;
Zwinderman, AH ;
Kuivenhoven, JA ;
Kastelein, JJP .
CIRCULATION, 2005, 111 (03) :278-287
[4]   Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women - The prospective EPIC (European Prospective Investigation into Cancer and Nutrition) - Norfolk population study [J].
Boekholdt, SM ;
Kuivenhoven, JA ;
Wareham, NJ ;
Peters, RJG ;
Jukema, JW ;
Luben, R ;
Bingham, SA ;
Day, NE ;
Kastelein, JJP ;
Khaw, KT .
CIRCULATION, 2004, 110 (11) :1418-1423
[5]   CETP gene variation: relation to lipid parameters and cardiovascular risk [J].
Boekholdt, SM ;
Kuivenhoven, JA ;
Hovingh, GK ;
Jukema, JW ;
Kastelein, JJP ;
van Tol, A .
CURRENT OPINION IN LIPIDOLOGY, 2004, 15 (04) :393-398
[6]   Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease [J].
Boekholdt, SM ;
Thompson, JF .
JOURNAL OF LIPID RESEARCH, 2003, 44 (06) :1080-1093
[7]   Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin : cholesterol acyltransferase and lipid transfer proteins [J].
Borggreve, SE ;
de Vries, R ;
Dullaart, RPF .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (12) :1051-1069
[8]   Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency -: Veterans Affairs HDL Cholesterol Intervention Trial [J].
Brousseau, ME ;
O'Connor, JJ ;
Ordovas, JM ;
Collins, D ;
Otvos, JD ;
Massov, T ;
McNamara, JR ;
Rubins, HB ;
Robins, SJ ;
Schaefer, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (07) :1148-1154
[9]   Comparison of laboratory parameters as risk factors for the presence and the extent of coronary or carotid atherosclerosis:: the significance of apolipoprotein B to apolipoprotein all ratio [J].
Cerne, D ;
Ledinski, G ;
Kager, G ;
Greilberger, J ;
Wang, XS ;
Jürgens, G .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (06) :529-538
[10]   INVESTIGATION OF LIPID TRANSFER IN HUMAN-SERUM LEADING TO THE DEVELOPMENT OF AN ISOTOPIC METHOD FOR THE DETERMINATION OF ENDOGENOUS CHOLESTEROL ESTERIFICATION AND TRANSFER [J].
CHANNON, KM ;
CLEGG, RJ ;
BHATNAGAR, D ;
ISHOLA, M ;
ARROL, S ;
DURRINGTON, PN .
ATHEROSCLEROSIS, 1990, 80 (03) :217-226